This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Strategies for Treatment of Metastases

James F. Huth, MD; Frederick R. Eilber, MD

Arch Surg. 1989;124(1):122-126.

Abstract
• We studied recurrence patterns in 255 patients with high-grade osteosarcoma of the extremity and the efficacy of the treatment of these recurrences. One hundred seven patients developed metastatic disease: 77 had isolated pulmonary metastases, 17 had simultaneous metastases to lung and elsewhere, and 13 had metastases to other sites. Of the 77 patients with metastases confined to the lung, 51 (66%) underwent thoracotomy for resection of the metastases, and 13 (17%) are long-term disease-free survivors. Patients with simultaneous metastases to lung and other sites, and patients with metastases to sites other than lung, have a poor prognosis with only one long-term disease-free survivor in these groups. Thoracotomy has a limited role in the treatment of metastatic disease. Improvements in aggressive, systemic chemotherapy are essential for improving the prognosis in these patients.

(Arch Surg 1989;124:122-126)

Author Affiliations
From the Department of Surgery, Division of Oncology, UCLA School of Medicine. Dr Huth is now with the University of North Carolina at Chapel Hill.

Footnotes
Accepted for publication Sept 21, 1988.

Read before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 25, 1988.

Reprint requests to Department of Surgery, The University of North Carolina at Chapel Hill, Burnett-Womack Clinical Sciences Building 229H, Chapel Hill, NC 27514 (Dr Huth).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients
Bielack et al.
JCO 2009;27:557-565.
ABSTRACT | FULL TEXT  

Prognostic factors of pulmonary metastasectomy for osteosarcomas of the extremities
Chen et al.
Eur. J. Cardiothorac. Surg. 2008;34:1235-1239.
ABSTRACT | FULL TEXT  

Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
Kempf-Bielack et al.
JCO 2005;23:559-568.
ABSTRACT | FULL TEXT  

Involvement of Chemokine Receptor 4/Stromal Cell-Derived Factor 1 System during Osteosarcoma Tumor Progression
Perissinotto et al.
Clin. Cancer Res. 2005;11:490-497.
ABSTRACT | FULL TEXT  

Persistent Knee Pain in a Recreational Runner
Paluska
J Am Board Fam Med 2003;16:435-442.
FULL TEXT  

Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
Ferrari et al.
JCO 2003;21:710-715.
ABSTRACT | FULL TEXT  

Metachronous Skeletal Osteosarcoma in Patients Treated with Adjuvant and Neoadjuvant Chemotherapy for Nonmetastatic Osteosarcoma
Aung et al.
JCO 2003;21:342-348.
ABSTRACT | FULL TEXT  

Effect of Timing of Pulmonary Metastases Identification on Prognosis of Patients With Osteosarcoma: The Japanese Musculoskeletal Oncology Group Study
Tsuchiya et al.
JCO 2002;20:3470-3477.
ABSTRACT | FULL TEXT  

Surgical Treatment and Chemotherapy for Pulmonary Metastases From Osteosarcoma
Skinner et al.
Arch Surg 1992;127:1065-1071.
ABSTRACT